NDRA
Endra Life Sciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NDRA Filings
Filing Date
Form Description
Form Type
2025-11-28
Form 8-K - Current report
Key Events
2025-11-28 · Key Events
Form 8-K - Current report
2025-11-26
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-11-26 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-11-26
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-26 ·
Form 424B4 - Prospectus [Rule 424(b)(4)]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form 8-K - Current report
Key Events
2025-11-14 · Key Events
Form 8-K - Current report
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-06
Form S-3 - Registration statement under Securities Act of 1933
2025-11-06 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-10-30
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-30 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-10-30
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-10-30 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
